Our Services
Medical Information
Helpful Resources
Published on: 5/21/2026
Maximum safe daily dose of Symbicort is 2 inhalations of the 160/4.5 µg strength twice daily (total 320 µg budesonide/9 µg formoterol per day), which provides optimal asthma and COPD control while limiting risks like tremors, rapid heartbeat, and adrenal suppression. Do not exceed this dosing regimen and ensure proper inhaler technique, regular lung function monitoring, and awareness of potential drug interactions.
There are several factors to consider regarding technique, side effects, monitoring schedules, and special populations—see below to understand more important details and next steps.
Symbicort (budesonide/formoterol) is a combination inhaler used for long-term management of asthma and chronic obstructive pulmonary disease (COPD). Knowing the maximum dose Symbicort daily safety limits helps you get the best benefit while minimizing risks. Below, you'll find clear, evidence-based guidance on dosing, safety considerations, and when to talk to your doctor.
Active ingredients
Indications
Dosage strengths
Based on clinical trials, prescribing information, and regulatory guidance, the maximum recommended daily dose is:
Asthma:
COPD:
Taking more than the maximum recommended dose may increase the risk of:
Avoid overuse
Regular monitoring
Side effects to watch for
Proper inhaler technique
Drug interactions
Even though Symbicort is designed for twice-daily use, accidental overuse can happen. Early signs of overdose include:
If you experience any of these, seek medical care immediately. For non-urgent breathing concerns or to better understand what your symptoms might mean, try this free Medically approved LLM Symptom Checker Chat Bot to get AI-powered insights before your next doctor visit.
Never ignore serious or life-threatening symptoms—always speak to a doctor right away.
This guide is based on current clinical guidelines and the U.S. prescribing information for Symbicort. If you have any questions about your dose or experience unusual symptoms, please speak to a doctor—your health is too important to leave to chance.
(References)
* Corren J, et al. Safety of high-dose budesonide/formoterol in patients with severe persistent asthma: a 12-week, multicenter, open-label study. J Asthma. 2008 Jun;45(5):373-81. doi: 10.1080/02770900802081919. PMID: 18569502.
* Yang LP, et al. Budesonide/formoterol: a review of its use in the treatment of asthma and COPD. Drugs. 2010 Oct 1;70(14):1851-87. doi: 10.2165/11200420-000000000-00000. PMID: 20860475.
* Rennard SI, et al. Safety and tolerability of budesonide/formoterol in COPD: a pooled analysis of 10 clinical studies. Pulm Pharmacol Ther. 2011 Dec;24(6):634-41. doi: 10.1016/j.pupt.2011.08.006. Epub 2011 Aug 27. PMID: 21896357.
* Nelson HS, et al. Pharmacokinetics, efficacy, and safety of budesonide/formoterol in a single inhaler for asthma: an update. J Allergy Clin Immunol. 2005 Sep;116(3):511-23. doi: 10.1016/j.jaci.2005.05.021. PMID: 16159620.
* Lipworth BJ. Systemic effects of inhaled corticosteroids: a review. Respir Med. 2010 Nov;104(11):1608-23. doi: 10.1016/j.rmed.2010.07.009. Epub 2010 Aug 17. PMID: 20719542.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.